The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
105038273 10503827 3 F 2014 20160825 20141008 20160831 PER US-PFIZER INC-2014275802 PFIZER 18.00 YR F Y 63.00000 KG 20160831 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
105038273 10503827 1 PS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 150 MG, UNK 21992 150 MG PROLONGED-RELEASE TABLET
105038273 10503827 2 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 100 MG (50MG X 2 TABLETS), DAILY 21992 100 MG PROLONGED-RELEASE TABLET
105038273 10503827 3 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 100 MG, 1X/DAY J30637 21992 100 MG PROLONGED-RELEASE TABLET QD
105038273 10503827 4 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 50 MG, 2X/DAY 21992 50 MG PROLONGED-RELEASE TABLET BID
105038273 10503827 5 C BACLOFEN. BACLOFEN 1 Oral 10 MG, 3X/DAY 0 10 MG TABLET TID
105038273 10503827 6 C BACLOFEN. BACLOFEN 1 0 TABLET
105038273 10503827 7 C LUTERA ETHINYL ESTRADIOLLEVONORGESTREL 1 Oral 0.01 MG, DAILY 0 .01 MG TABLET
105038273 10503827 8 C MIRTAZAPINE. MIRTAZAPINE 1 Oral 30 MG, 1X/DAY AT BEDTIME 0 30 MG TABLET QD
105038273 10503827 9 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral 4 MG, AS NEEDED 0 4 MG TABLET
105038273 10503827 10 C LANSOPRAZOLE. LANSOPRAZOLE 1 Oral 30 MG, 2X/DAY 0 30 MG CAPSULE BID
105038273 10503827 11 C MECLIZINE MECLIZINE HYDROCHLORIDE 1 Oral 25 MG, AS NEEDED 0 25 MG TABLET
105038273 10503827 12 C DICYCLOMINE DICYCLOMINE HYDROCHLORIDE 1 Oral 10 MG, AS NEEDED 0 10 MG CAPSULE

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
105038273 10503827 1 Post-traumatic stress disorder
105038273 10503827 2 Panic attack
105038273 10503827 5 Gastrooesophageal reflux disease
105038273 10503827 6 Fibromyalgia
105038273 10503827 7 Contraception
105038273 10503827 8 Insomnia
105038273 10503827 9 Nausea
105038273 10503827 10 Gastrooesophageal reflux disease
105038273 10503827 11 Vertigo
105038273 10503827 12 Gastrooesophageal reflux disease

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
105038273 10503827 Abdominal pain
105038273 10503827 Anger
105038273 10503827 Drug ineffective for unapproved indication
105038273 10503827 Dyspepsia
105038273 10503827 Dysphagia
105038273 10503827 Frustration tolerance decreased
105038273 10503827 Medication residue present
105038273 10503827 Mood altered
105038273 10503827 Product quality issue
105038273 10503827 Product use issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
105038273 10503827 1 201110 0
105038273 10503827 3 2014 0
105038273 10503827 4 20160824 0
105038273 10503827 7 2014 0
105038273 10503827 11 2014 0